瑞丽医美(02135.HK)附属认购莱丽医美51%股权 代价255万港元

Group 1 - The core announcement involves a subscription agreement between Miao Shi Aesthetics, investors, shareholders, and the target company, Laili Medical Limited, dated January 6, 2026 [1] - The first investor agrees to subscribe for a total of 170,000 shares at a subscription price of HKD 2,550,000, while the second investor, Bif Limited, agrees to subscribe for 63,335 shares at a price of HKD 950,000 [1] - Upon completion, Miao Shi Aesthetics, the first investor, and the second investor will hold 30.0%, 51.0%, and 19.0% of the target company's shares, respectively [1]